Racial or ethnic differences on treatment adherence and persistence among patients with inflammatory bowel diseases initiated with biologic therapies
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-230X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Racial or ethnic differences on treatment adherence and persistence among patients with inflammatory bowel diseases initiated with biologic therapies ; volume:22 ; number:1 ; day:29 ; month:12 ; year:2022 ; pages:1-12 ; date:12.2022
BMC gastroenterology ; 22, Heft 1 (29.12.2022), 1-12, 12.2022
- Urheber
-
Cai, Qian
Ding, Zhijie
Fu, Alex Z.
Patel, Aarti A.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12876-022-02560-y
- URN
-
urn:nbn:de:101:1-2023031021034977673912
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:55 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Cai, Qian
- Ding, Zhijie
- Fu, Alex Z.
- Patel, Aarti A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Risk of Cutaneous T Cell Lymphoma with Psoriasis Biologic Therapies
Factors influencing the discontinuation of biologic therapies in patients with ulcerative colitis
PReS13-SPK-1129: Biologic therapies in SLE
Weighted Breaths: Exploring Biologic and Non-Biologic Therapies for Co-Existing Asthma and Obesity
Emerging Biologic Therapies for the Treatment of Atopic Dermatitis
Biologic system evaluation with ultrasound
Do biologic therapies reduce aortic inflammation in rheumatoid arthritis patients?
What is the impact of biologic therapies on common co-morbidities in patients with rheumatoid arthritis?
Amongst patients taking biologic therapies for axial spondyloarthritis, which factors are associated with work non-participation?
Canadian Rhinology Working Group consensus statement: biologic therapies for chronic rhinosinusitis
Immunogenicity of biologic therapies for migraine: a review of current evidence
Biologic Therapy for Moderate to Severe Psoriasis. Real-World Follow-up of Patients Who Initiated Biologic Therapy at Least 10 Years Ago
Risk of Cutaneous T Cell Lymphoma with Psoriasis Biologic Therapies
Factors influencing the discontinuation of biologic therapies in patients with ulcerative colitis
PReS13-SPK-1129: Biologic therapies in SLE
Weighted Breaths: Exploring Biologic and Non-Biologic Therapies for Co-Existing Asthma and Obesity
Emerging Biologic Therapies for the Treatment of Atopic Dermatitis
Biologic system evaluation with ultrasound
Do biologic therapies reduce aortic inflammation in rheumatoid arthritis patients?
What is the impact of biologic therapies on common co-morbidities in patients with rheumatoid arthritis?
Amongst patients taking biologic therapies for axial spondyloarthritis, which factors are associated with work non-participation?
Canadian Rhinology Working Group consensus statement: biologic therapies for chronic rhinosinusitis
Immunogenicity of biologic therapies for migraine: a review of current evidence
Biologic Therapy for Moderate to Severe Psoriasis. Real-World Follow-up of Patients Who Initiated Biologic Therapy at Least 10 Years Ago
Risk of Cutaneous T Cell Lymphoma with Psoriasis Biologic Therapies
Factors influencing the discontinuation of biologic therapies in patients with ulcerative colitis
PReS13-SPK-1129: Biologic therapies in SLE
Weighted Breaths: Exploring Biologic and Non-Biologic Therapies for Co-Existing Asthma and Obesity
Emerging Biologic Therapies for the Treatment of Atopic Dermatitis
Biologic system evaluation with ultrasound
Do biologic therapies reduce aortic inflammation in rheumatoid arthritis patients?
What is the impact of biologic therapies on common co-morbidities in patients with rheumatoid arthritis?
Amongst patients taking biologic therapies for axial spondyloarthritis, which factors are associated with work non-participation?
Canadian Rhinology Working Group consensus statement: biologic therapies for chronic rhinosinusitis
Immunogenicity of biologic therapies for migraine: a review of current evidence